The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
Lin, JianMin, Spidel, Jared L, Maddage, Christopher J, Rybinski, Katherine A, Kennedy, Rina P, Krauthauser, Candice LM, Park, Young Chul, Albone, Earl F, Jacob, Sara, Goserud, Matthew T, Martinez, Bryon P, Chao, Qimin, Zhou, Yuhong, Nicolaides, Nicholas C, Kline, J Bradford, Grasso, Luigi
Published in Cancer biology & therapy (01.11.2013)
Published in Cancer biology & therapy (01.11.2013)
Get full text
Journal Article